Sector Gamma AS’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.84M Sell
60,402
-36,000
-37% -$2.97M 1.14% 31
2025
Q4
$8.22M Buy
96,402
+23,422
+32% +$1.92M 1.87% 20
2025
Q3
$5.68M Buy
72,980
+30,980
+74% +$2.42M 1.41% 28
2025
Q2
$3.28M Sell
42,000
-81,000
-66% -$6.04M 1.07% 32
2025
Q1
$8.92M Buy
123,000
+24,000
+24% +$1.72M 2.86% 15
2024
Q4
$7.33M Sell
99,000
-7,153
-7% -$501K 2.52% 17
2024
Q3
$7.01M Buy
106,153
+37,000
+54% +$2.69M 2.13% 18
2024
Q2
$6.39M Sell
69,153
-37,713
-35% -$3.34M 2.39% 19
2024
Q1
$10.2M Sell
106,866
-80,690
-43% -$6.78M 2.88% 16
2023
Q4
$14.3M Sell
187,556
-25,439
-12% -$1.77M 3.47% 13
2023
Q3
$14.8M Buy
212,995
+17,704
+9% +$1.42M 3.77% 12
2023
Q2
$18.4M Buy
195,291
+36,485
+23% +$3.17M 4.12% 10
2023
Q1
$13.1M Sell
158,806
-15,446
-9% -$1.21M 3.19% 12
2022
Q4
$13M Buy
+174,252
New +$13.4M 2.97% 16
2015
Q2
Sell
-663,000
Closed -$15.7M 27
2015
Q1
$15.7M Sell
663,000
-304,200
-31% -$6.82M 4.16% 9
2014
Q4
$20.5M Sell
967,200
-456,600
-32% -$9.17M 4.57% 6
2014
Q3
$24.2M Sell
1,423,800
-378,000
-21% -$5.97M 5.67% 4
2014
Q2
$25.8M Sell
1,801,800
-79,800
-4% -$1.08M 6.1% 4
2014
Q1
$23.3M Buy
1,881,600
+579,600
+45% +$6.69M 5.58% 4
2013
Q4
$14.3M Buy
1,302,000
+222,000
+21% +$2.5M 3.85% 8
2013
Q3
$12.5M Buy
+1,080,000
New +$12.6M 3.22% 11

Other funds holding EW

Sector Gamma AS's EW Position: Q1 2026 in Review

Sector Gamma AS reduced its Edwards Lifesciences (EW) stake by 37% in Q1 2026, selling an estimated $2.97M and leaving 60,402 shares worth $4.84M. The position accounts for 1.14% of the portfolio, ranked #31.

Sector Gamma AS first reported a position in EW in Q3 2013 and has held it in 21 quarters since. The position peaked at $25.8M in Q2 2014. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Sector Gamma AS held 60,402 shares of Edwards Lifesciences worth $4.84M as of Q1 2026.
  • Sector Gamma AS sold 36,000 Edwards Lifesciences shares in Q1 2026, an estimated $2.97M.
  • Edwards Lifesciences made up 1.14% of Sector Gamma AS's portfolio in Q1 2026, its #31 holding.
  • Sector Gamma AS first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 21 quarters since.
  • Sector Gamma AS's Edwards Lifesciences position peaked at $25.8M in Q2 2014.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.